SiNtx Technologies Inc (SINT)

[boston745]

Zimmer Biomets mentioned for two main reasons and it is not to illustrate Sintx value. To demonstrate Sintx value, you look at Implex for a comparable materials company to get an idea of Si3n4's worth within the ortho industry only; ~230m based on a market that was 1/3rd the size it is today. You look at the industries the IP can be used in. Lastly you look at the partners Sintx appears to be working with to help it potentially commercialize its products in those industries.
One of the main reasons for mentioning Zimmer Biomet is this, to show that Sintx has large partnership to help it commercialize its products and that this particular company has been working with Sintx for going on 20 years. Sintx partnerships are key to its success due to how Sintx is setup to generate revenue: license its IP/supply blanks/powder as i said in a previous post. Its not setup to sell direct to market. This reduces costs and risk of scaling operations while also reducing maximum potential revenue. However that makes it very dependent on its partners. Thats why i used a scenario of 5% licensing fee and 5% penetration of markets that are well over 300bn in size to come up with 800m in revenue. Sintx, with its partners should be able to penetrate several of those markets far greater than 5% but i used that as an average across all those industries.
Below shows the connections to Zimmer Biomet & Morgan Ceramics/NP Aerospace. I bring up Solventum because Zimmer Biomets former CEO Bryan Hanson is now CEO of Solventum and knows all about Sintx IP from his Zimmer days. Thus i could see Solventum being one of Sintx partners in relation to Wound Care & possibly cancer related products via biofarma filtration using Si3n4 based membrane. I bring up Cardinal Health because of Sintx hire of Joseph Palomo who came from Cardinal Health R&D division. Again a potential partner in relation to PPE & Catheters.
Sintx has a pattern of hiring individuals from large companies it works with like Zimmer Biomet, possibly Cardinal Health, Morgan Ceramics. Those hires all seem to come to Sintx to help it set itself up to supply products in the same industries those companies operate in. Thus i strongly suspect they join to get Sintx ready to supply the company they came from.

Cardinal Health

Palomo joins SINTX with over 40 years of experience in protective apparel and PPE, such as surgical gowns, surgical drapes, isolation gowns, films, tubing, and surgical face masks.

https://ir.sintx.com/news-events/press-releases/detail/184/sintx-technologies-provides-update-on-antipathogenic

Bryan Hanson & 3M's Solventum

wound care, oral care, health care IT, and biopharma filtration

https://news.3m.com/2023-08-22-Bryan-Hanson-Named-CEO-of-3Ms-Health-Care-Business-Group

Ultrathin silicon nitride membrane with slit-shaped pores for high-performance separation of circulating tumor cells
https://pubmed.ncbi.nlm.nih.gov/35997043/

========================================

A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.

AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.

https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1

Silicon Nitride = Next Gen Hip implant material

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/

Sintx - Zimmer Personel Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353

Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294

Sintx - Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136

Sintx Intellectual Property is worth more than $230m as shown by Zimmers acquisition of Implex in 2003
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174493456:

Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660

Zimmer Biomet Hires Si3N4 Coatings Expert for its anti-infective dvision - December 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529

Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Dr Bal's investment company loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867

Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439

Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.

One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant